添加羊乳粉对乙型肝炎肝硬化患者营养状态及肝脏合成功能的影响

doi:10.3969/j.issn.1672-5069.2016.01.016

实用肝脏病杂志 ›› 2016, Vol. 19 ›› Issue (1): 64-67.doi: 10.3969/j.issn.1672-5069.2016.01.016

添加羊乳粉对乙型肝炎肝硬化患者营养状态及肝脏合成功能的影响

朱慧, 郭红英, 黄大青, 张宇一, 张正国, 邹颖, 王介非, 钱志平

201508上海市复旦大学附属公共卫生临床中心重症肝炎/ICU科

收稿日期:2015-03-07 出版日期:2016-01-10 发布日期:2016-02-04
通讯作者: 钱志平,E-mail：qianzhiping@shaphc.org
作者简介:朱慧,女,40岁,主治医师。主要从事肝衰竭诊治研究。E-mail：zhuhui@shaphc.org

Improvement of goat milk powder diet on nutrition states and synthetic function of liver in patients with hepatitis B-induced cirrhosis

Zhu Hui, Guo Hongying, Huang Daqing, Zhang Yuyi, Zhang Zhengguo, Zou Ying, Wang Jiefei, Qian Zhiping

Department of Intensive Care Unit,Public Health Clinical Center,Fudan University,Shanghai 201508

Received:2015-03-07 Online:2016-01-10 Published:2016-02-04
Contact: Corresponding author: Qian Zhiping,E-mail:qianzhiping@shaphc.org

摘要/Abstract

摘要： 目的探讨羊乳粉对乙型肝炎肝硬化患者营养状态及肝脏合成功能的影响。方法选取我科诊治的乙型肝炎肝硬化患者80例,按患者意愿分为羊乳粉营养支持治疗组40例和常规饮食对照组40例。所有患者均参照2006年欧洲肠外肠内营养学会制定的肝病肠内营养指南给予总热量35 kcal·kg^-1·d^-1,蛋白质的摄入量为1.2~1.5 kcal·kg^-1·d^-1。治疗组患者除正常饮食外,每日分别于晨起空腹和睡前各给予卡布瑞克羊乳粉30 g,加60℃温水冲服,1次/d,服用12 w。分别于4 w、8 w和12 w测定患者体质指数、上臂肌围,检测外周血白蛋白、前白蛋白、转铁蛋白、胆碱酯酶、总胆红素、血氨、甘油三酯、空腹血糖水平。应用SPSS 16.0统计软件,两组间计量资料的比较采用t检验。结果在第4 w和第8 w时,两组患者体质指数和上臂肌围的差异均无统计学意义（P>0.05）;在第12 w时,治疗组患者体质指数为（23.36±1.26） kg/m²,显著高于对照组[（22.30±1.80） kg/m²,t=3.021,P<0.05],上臂肌围为（27.89±2.85） cm,显著高于对照组[（26.16±3.04） cm,t=2.766,P<0.05],白蛋白为（34.93±1.63）g/L,显著高于对照组[（32.04±1.80） g/L,t=7.597,P<0.05],前白蛋白为（91.97±21.14） mg/L,显著高于对照组[（76.92±15.94） mg/L,t=3.415,P<0.05],转铁蛋白为（1.69±0.35） mg/L,显著高于对照组[（1.50±0.34） mg/L,t=2.315,P<0.05]和胆碱酯酶为（2785±516） U/L,显著高于对照组[（2546±487） U/L,t=2.105,P<0.05];而与对照组比,治疗组患者血清总胆红素、血氨、甘油三酯和空腹血糖水平无统计学差异。结论添加羊乳粉能有效改善乙型肝炎肝硬化患者的营养状况,提高肝脏的合成功能。

关键词: 肝硬化, 乙型肝炎, 羊乳粉, 营养

Abstract: Objective To observe the effects of goat milk powder diet on nutrition condition and synthetic function of liver in patients with hepatitis B-induced liver cirrhosis. Methods Eighty patients with hepatitis B-related liver cirrhosis were enrolled in this study,and 40 cases were treated with goat milk powder in treatment group and 40 cases were treated with regular dieteric were treatment in control group. Evaluation of nutrition condition and liver function tests were conducted for 12 weeks in both groups. Analyses were carried out by using t test. Results At 4 week and 8 week observation,there was no significant difference of nutrition indicators and liver synthetic funtion,including body mass index,arm muscle circumference,serum albumin,pre-albumim,transferrin and cholinesterase levels between the two groups;the body mass index [（23.36±1.26） kg/m² vs. （22.30±1.80） kg/m², t=3.021,P<0.05],arm muscle circumstance[（27.89±2.85） cm vs.（26.16±3.04） cm,t=2.766,P<0.05],albulmin [（34.93±1.63） g/L vs.（32.04±1.80） g/L,t=7.597,P<0.05],pre-albulmin [（91.97±21.14） mg/L vs. （76.92±15.94）mg/L,t=3.415,P<0.05],transferrin [（1.69±0.35） mg/L vs.（1.50±0.34） mg/L,t=2.315,P<0.05] and cholinesterase[（2785±516）U/L vs.（2546±487） U/L,t=2.105,P<0.05] in the treatment group at week 12 were significantly increased as compared to those in the control group,while the serum levels of total bilirubin,blood ammonia, plasma triglyceride and blood sugar showed no significant differences between the two groups. Conclusions Dietary intervention with goat milk powder can improve nutrition condition and liver synthetic function in patients with hepatitis B-induced liver cirrhosis.

Key words: Liver cirrhosis, Hepatitis B, Goat milk powder, Nutrition

朱慧, 郭红英, 黄大青, 张宇一, 张正国, 邹颖, 王介非, 钱志平. 添加羊乳粉对乙型肝炎肝硬化患者营养状态及肝脏合成功能的影响[J]. 实用肝脏病杂志, 2016, 19(1): 64-67.

Zhu Hui, Guo Hongying, Huang Daqing, Zhang Yuyi, Zhang Zhengguo, Zou Ying, Wang Jiefei, Qian Zhiping. Improvement of goat milk powder diet on nutrition states and synthetic function of liver in patients with hepatitis B-induced cirrhosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(1): 64-67.

参考文献

[1] Kalaitzakis E,Simrén M,OIsson R,et al. Gastrointestinal symptoms in patients with liver cirrhosis:associations with nutritional status and health-related quality of life. Scand J Gastroenterol,2006,41（12）:1464-1472．
[2] Juakiem W,Torres DM,Harrison SA. Nutrition in cirrhosis and chronic liver disease. Clin Liver Dis,2014,18（1）:179-190.
[3] Guglielmi FW,Panella C,Buda A,et al. Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology （SIGE）. Dig Liver Dis,2005,37（9）:681-688.
[4] Plauth M,Cabré E,Riggio O,et al. ESPEN Guidelines on Enteral Nutrition:Liver disease. Clin Nutr,2006,25（2）:285-294.
[5] 中国肥胖问题工作组数据汇总分析协作组．我国成人体重指数和腰围对相关疾病危险因素异常的预测价值：适宜体重指数和腰围切点的研究. 中华流行病学杂志,2002,23（1）:5-10．
[6] 蔡东联. 实用营养师手册. 上海:第二军医大学出版社,1998:505-514.
[7] 丁惠国, 汪俊韬, 王宝恩. 肝硬化患者营养不良、能量代谢异常与营养支持. 中国临床营养杂志,2002,10（4）:281-283.
[8] 杨先芬, 荚卫东. 肝硬化患者营养状况与营养支持. 实用肝脏病杂志,2012,15（2）:174-176.
[9] 段忠平. 肝病营养问题再关注. 实用肝脏病杂志,2014,17（5）:449-451.
[10] Alberino F,Gatta A,Amodio P,et al. Nutrition and survival in patients with liver cirrhosis. Nutrition,2001,17（6）:445-450.
[11] 曹海霞, 范建高. 肝硬化患者营养评估及营养支持治疗. 实用肝脏病杂志,2014,17（5）:459-462.
[12] Tsiaousi ET,Hatzitolios AI,Trygonis SK,et al. Malnutrition in end stage liver disease:recommendations and nutritional support. J Gastroenterol Hepatol,2008,23（4）:527-533.
[13] O'Brien A1,Williams R. Nutrition in end-stage liver disease: principles and practice. Gastroenterology,2008,134（6）:1729-1740.
[14] 邓茜, 姜勇, 王丽敏. 中国成年人体重指数与生命质量的关系研究. 中华流行病学杂志,2014,35（5）:557-561.
[15] 吴国豪. 人体组成测定及临床意义. 肠内及肠外营养,2002,9（1）:51-56.
[16] Allard JP,Aghdassi E,MeArthur M,et al. Nutrition risk factors for survival in the elderly living in Canadian long-term care facilities. J Am Geriatr Soc,2004,52（1）:59-65.
[17] Kudsk KA,Tolley EA,DeWitt RC,et al. Preoperative albumin and surgical site identify surgical risk for major postoperative complication. JPEN,2003,27（1）:1-9.
[18] Cordoba J,Lopez-Hell'n J,Planas M,et al. Normal protein for episodic hepatic encephalopathy:results of a randomized trial. J Hepatol,2004,41（1）:38-43.
[19] Amodio P,Bemeur C,Butterworth R,et al. The nutritional management of hepatic encephalopathy in patients with cirrhosis:International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Hepatology,2013,58（1）:325-336.
[20] Amodio P,Bemeur C,Butterworth R. et al. The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus. Hepatology,2013,58（1）:325-36.

添加羊乳粉对乙型肝炎肝硬化患者营养状态及肝脏合成功能的影响

Improvement of goat milk powder diet on nutrition states and synthetic function of liver in patients with hepatitis B-induced cirrhosis

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	庄莹, 林志辉. 肝硬化并发门静脉血栓临床表现和诊断进展[J]. 实用肝脏病杂志, 2019, 22(6): 765-767.
[2]	朱凌云, 张茂海, 崔莎莎, 张秋萍. 慢性乙型肝炎患者血清IL-12、IL-18水平和外周血单个核细胞FOXp3基因水平研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 816-819.
[3]	石莹莹, 王元喜. 替比夫定联合阿德福韦酯治疗慢性乙型肝炎患者效果及其对肾功能的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 820-823.
[4]	闵峰, 黄文琪, 吴卫兵, 张丽, 范荣华. 慢性乙型肝炎患者血清脂肪细胞因子水平变化及其临床意义^*[J]. 实用肝脏病杂志, 2019, 22(6): 824-827.
[5]	张迎明, 申爽, 田飞, 孙园园. IFNL4和IL-28B基因多态性检测评估慢性乙型肝炎患者抗病毒治疗应答价值分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 828-831.
[6]	吴海义, 陈建新. 四种诊断模型诊断乙型肝炎病毒携带者肝纤维化的效能分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 832-835.
[7]	马丽英, 沈利娟. 妊娠后期应用替诺福韦治疗血清HBV高载量孕妇阻断HBV母婴传播的疗效及安全性分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 836-839.
[8]	杨才勇, 陈娜, 李奎, 江自成, 卜蓉蓉. 慢性丙型肝炎和丙型肝炎肝硬化患者外周血Treg和Th17水平变化临床意义探讨^*[J]. 实用肝脏病杂志, 2019, 22(6): 868-871.
[9]	朱娅鸽, 刘锦峰. 丁二磺酸腺苷蛋氨酸联合复方甘草酸苷治疗酒精性肝硬化患者疗效及其对血清BGP水平的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 872-875.
[10]	武丹, 马向鹰. 非酒精性脂肪性肝病肝硬化患者胰岛素抵抗水平与颈动脉硬化程度和左心室功能研究^*[J]. 实用肝脏病杂志, 2019, 22(6): 876-879.
[11]	陈梅梅, 段晓燕, 曹海霞, 丁雯瑾. 复方鳖甲软肝片治疗原发性胆汁性肝硬化患者疗效分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 880-883.
[12]	刘李, 杨烈, 陈海洋, 何承俊, 王建宇, 陈廷昊. 肝硬化门静脉高压症并发脾动脉盗血综合征患者脾切除联合贲门周围血管离断术后门脉血流动力学的变化^*[J]. 实用肝脏病杂志, 2019, 22(6): 884-887.
[13]	何志安, 余丽萍, 赖江琼, 黄思付. ARFI评估肝硬化并发食管胃底静脉曲张患者出血和门静脉血栓的价值分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 888-891.
[14]	马雅琼, 李芝兰, 夏冰. 早期肠内营养联合微生态制剂治疗肝性脑病患者肠道菌群的改变^*[J]. 实用肝脏病杂志, 2019, 22(6): 892-895.
[15]	李传杰, 徐静, 王亮亮, 潘劲劲, 刘波. 恩替卡韦治疗慢性乙型肝炎患者血清HBsAg变化与病毒学应答的相关性研究[J]. 实用肝脏病杂志, 2019, 22(6): 928-929.